tradingkey.logo
tradingkey.logo
Search

Cellectar Biosciences Inc

CLRB
Add to Watchlist
2.570USD
+0.040+1.58%
Close 07-31 16:00ETQuotes delayed by 15 min
10.90MMarket Cap
LossP/E TTM

CLRB Financials

See Cellectar Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cellectar Biosciences Inc Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
--/-0.48
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-8.35
77.12%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
68.99%-1.33
23.50%-1.29
87.43%-1.41
-339.72%-3.39
84.21%-4.30
89.27%-1.68
75.94%-11.18
96.48%-0.77
-19.14%-27.24
28.23%-15.71
---46.48
---21.90
---22.86
---21.88
----
----
----
----
----
----
Net Profit
14.39%-5.65M
-124.81%-5.30M
69.70%-4.44M
-492.57%-5.45M
75.21%-6.60M
70.11%-2.36M
16.30%-14.66M
88.82%-919.37K
-210.47%-26.64M
-9.23%-7.88M
-124.29%-17.52M
-10.57%-8.22M
-39.76%-8.58M
-21.92%-7.22M
-34.24%-7.81M
-23.34%-7.44M
3.42%-6.14M
-63.71%-5.92M
-48.84%-5.82M
-66.89%-6.03M
Operating profit
9.48%-5.79M
55.35%-5.69M
63.60%-4.85M
55.94%-6.04M
46.67%-6.40M
-1.57%-12.74M
-41.58%-13.33M
-65.22%-13.70M
-37.86%-12.00M
-69.05%-12.55M
-20.45%-9.41M
-11.55%-8.29M
-41.77%-8.71M
-25.31%-7.42M
-34.29%-7.82M
-23.34%-7.44M
3.45%-6.14M
-55.90%-5.92M
-48.84%-5.82M
-66.44%-6.03M
Net Profit
14.39%-5.65M
-124.81%-5.30M
69.70%-4.44M
-492.57%-5.45M
75.21%-6.60M
70.11%-2.36M
16.30%-14.66M
88.82%-919.37K
-210.47%-26.64M
-9.23%-7.88M
-124.29%-17.52M
-10.57%-8.22M
-39.76%-8.58M
-21.92%-7.22M
-34.24%-7.81M
-23.34%-7.44M
3.42%-6.14M
-63.71%-5.92M
-48.84%-5.82M
-66.89%-6.03M
Current assets
-37.77%9.27M
-42.11%14.04M
-62.06%13.62M
-54.78%12.62M
-64.00%14.89M
131.99%24.25M
78.51%35.90M
397.45%27.91M
198.77%41.37M
-49.08%10.45M
7.19%20.11M
-77.81%5.61M
-55.90%13.85M
-43.86%20.53M
-54.68%18.76M
-46.34%25.29M
-42.29%31.39M
-36.88%36.57M
109.02%41.39M
104.50%47.12M
Total current liabilities
-19.05%4.87M
-49.40%4.75M
-75.82%4.91M
-61.32%5.87M
-62.99%6.02M
-27.44%9.39M
23.34%20.31M
135.34%15.17M
133.88%16.27M
133.98%12.94M
152.81%16.47M
14.97%6.45M
49.54%6.96M
38.57%5.53M
105.79%6.52M
59.33%5.61M
-7.34%4.65M
11.99%3.99M
-19.96%3.17M
5.99%3.52M
Total assets
-30.68%11.12M
-41.20%14.98M
-60.78%14.63M
-53.39%13.70M
-62.61%16.04M
110.96%25.47M
73.05%37.29M
351.44%29.38M
189.17%42.91M
-44.07%12.08M
11.55%21.55M
-74.86%6.51M
-53.62%14.84M
-41.97%21.59M
-53.95%19.32M
-45.76%25.89M
-41.90%31.99M
-36.58%37.20M
102.71%41.95M
100.14%47.74M
Total liabilities
-0.06%6.40M
-48.36%5.06M
-74.70%5.25M
-60.13%6.23M
-61.73%6.41M
-27.06%9.80M
22.15%20.75M
123.93%15.62M
123.11%16.74M
120.83%13.43M
158.54%16.98M
22.42%6.98M
56.95%7.50M
46.33%6.08M
95.05%6.57M
51.77%5.70M
-9.60%4.78M
7.55%4.16M
-24.71%3.37M
-2.92%3.75M
Total equity
-51.04%4.72M
-36.73%9.92M
-43.32%9.38M
-45.75%7.47M
-63.18%9.64M
1256.06%15.68M
262.30%16.55M
3047.08%13.76M
256.76%26.17M
-108.74%-1.36M
-64.18%4.57M
-102.31%-467.00K
-73.04%7.33M
-53.07%15.51M
-66.96%12.75M
-54.09%20.19M
-45.34%27.21M
-39.69%33.05M
137.83%38.59M
120.08%43.98M
Net operating income
48.36%-4.85M
60.19%-4.34M
53.36%-4.28M
63.82%-5.12M
29.77%-9.38M
-13.73%-10.91M
-13.62%-9.17M
-87.80%-14.14M
-86.00%-13.36M
-29.47%-9.60M
-15.04%-8.07M
-30.78%-7.53M
-42.54%-7.18M
-64.30%-7.41M
-9.09%-7.01M
16.27%-5.76M
-6.04%-5.04M
-16.60%-4.51M
-83.58%-6.43M
-125.46%-6.88M
Net investment
---3.38K
90.41%-5.88K
--0.00
----
----
77.03%-61.29K
100.00%0.00
---21.28K
---21.63K
-126.34%-266.76K
-8352.90%-597.28K
100.00%0.00
100.00%0.00
9.16%-117.86K
-73.91%-7.07K
-839.00%-70.98K
---30.07K
-653.86%-129.74K
---4.06K
78.15%-7.56K
Net financing
----
--4.99M
-67.04%5.79M
225137900.00%2.25M
----
-100.00%0.00
-21.94%17.56M
--1.00
1461648800.00%43.85M
-95.41%441.00K
--22.50M
--0.00
--3.00
961065600.00%9.61M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%-1.00
100.00%0.00
-99.81%34.87K

FAQs

What are the current assets of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its current assets were 14.04M, with a year-on-year change of -42.11.

What are the total assets of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its total assets of Cellectar Biosciences Inc were 14.98M, with a year-on-year change of -41.20.

What are the total liabilities of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its total liabilities of Cellectar Biosciences Inc were 5.06M, with a year-on-year change of -48.36.

What is the total equity of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its total equity of Cellectar Biosciences Inc was 9.92M, with a year-on-year change of -36.73.

What is the net operating income of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its net operating income of Cellectar Biosciences Inc was -22.98M, with a year-on-year change of 55.62.

What is the net investment of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its net investment of Cellectar Biosciences Inc was -5.88K, with a year-on-year change of 94.36.

What is the net financing of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its net financing of Cellectar Biosciences Inc was 13.03M, with a year-on-year change of -78.78.

What is the Earnings Per Share (EPS) of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -8.35, with a year-on-year change of 77.12.

What is the net income of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its net income was -21.79M, with a year-on-year change of 51.12.

What is the Return on Equity (ROE) of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -200.01, with a year-on-year change of 85.74.

What is the Return on Assets (ROA) of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -107.74, with a year-on-year change of 54.63.

What is the operating profit of Cellectar Biosciences Inc?

According to Cellectar Biosciences Inc's FY2025 earnings report, its operating profit was -22.98M, with a year-on-year change of 55.62.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.